scorecardresearch
Add as a preferred source on Google
Tuesday, March 10, 2026
TopicNovo Nordisk

Topic: Novo Nordisk

In battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on other

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

Eli Lilly announces trial results for world’s 2nd weekly insulin, aims for launch by year-end

New Delhi: There is excitement and hope in the insulin market the world over after U.S. based pharma giant Eli Lilly & Company on...

Ozempic on steroids? Successor that could cut down weight in half the time coming soon

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its effectiveness in obesity management come out in 3 months.

On Camera

Badshah’s ‘Teteeree’ shows what is wrong with Bollywood’s ‘brand of creativity’

This also tells that everything that rhymes is music, and everyone who can string together catchy lines is an artist. Badshah’s work is a reminder of that uncomfortable truth.

Centre invokes Essential Commodities Act to regulate gas supply as Iran and US-Israel conflict rages on

Gazette notification prioritises household fuel, transport gas and fertiliser sector as West Asia tensions raise concerns over energy supplies

India and Indonesia finalise BrahMos deal, contract to be signed early next fiscal

One battery of the BrahMos missile is to be procured in the initial phase. The plan is to scale up the procurement in phases.

Trump brings the Age of Humiliation for friends. Modi needs stoicism abroad, humility at home

Trump has ushered in the age of humiliation. His method is to push around America’s friends rudely and publicly. He knows none of them can afford to fight back.